From: Hepatocellular carcinoma and the penetrance of HFEC282Y mutations: a cross sectional study
HCC Patients | Controls * | ||
---|---|---|---|
Mean Age | 54 a | 57 | |
CC (normal) | 119 (82.6%) | 1331 (88.2%) | |
CY (heterozygotes) | 17 (11.8%) | 168 (11.1%) | p = 0.34 |
YY (homozygotes) | 8 (5.6%) | 9 (0.6%) | p = 0.00003 |
Total Number | 144 | 1508 |